We assumed that the determination of the CTA expression profile GAGE, HAGE, NY-ESO1, MAGEA1, PASD1, SCP1, SEMG1, SLLP1, SPANXA1, SSX1, and PRAME will allow characterizing in sufficient detail the immunophenotype of the tumor cells that can be used for the preparation of lysate during DC vaccine production. This evidence concerns the gene PASD1 and neoplasm.